Active	Status	Sponsor type	Region	Phase	Filter
8 Active 0 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Bertolet, Barry
VICTORION-2P, NCT05030428: Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease	Active, not recruiting	3	17006	Europe, Canada, Japan, US, RoW	Inclisiran sodium 300 mg, Placebo	Novartis Pharmaceuticals	Atherosclerotic Cardiovascular Disease	10/27	10/27
VICTORION-1 PREVENT, NCT05739383: A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.	Recruiting	3	14000	Europe, Canada, US, RoW	Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL, KJX839, Placebo in 1.5ml	Novartis Pharmaceuticals	Primary Prevention of Atherosclerotic Cardiovascular Disease	04/29	04/29
NCT05562934: An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.	Active, not recruiting	2	191	Europe, Japan, US, RoW	Experimental drug, Placebo	Novartis Pharmaceuticals	Resistant Hypertension	07/24	08/24
NCT05198674: SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN	Recruiting	N/A	1400	Europe, US, RoW	Renal Denervation (Symplicity Spyral™), Renal Angiography, Renal Denervation	Medtronic Vascular	Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus	11/26	11/29
FORWARD PAD, NCT05858905: IDE Study With the Shockwave Mini S IVL Catheter	Active, not recruiting	N/A	75	US	Intravascular Lithotripsy	Shockwave Medical, Inc.	Peripheral Arterial Disease	04/24	04/25
ALLEVIATE-HF, NCT04452149: Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure	Recruiting	N/A	900	US	Reveal LINQ™ Insertable Cardiac Monitor with investigational ALLEVIATE-HF RAMware download, Medication intervention	Medtronic Cardiac Rhythm and Heart Failure	Heart Failure NYHA Class II, Heart Failure NYHA Class III	04/25	04/25
MAGICAL ISR, NCT05908331: MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions	Recruiting	N/A	492	US	Sirolimus Drug Coated Balloon, Plan balloon Angioplasty (POBA)	Concept Medical Inc., Cardiovascular Research Foundation, New York	In-Stent Restenosis, Cardiovascular Diseases, Coronary Artery Disease	09/25	02/28
LUX-Dx TRENDS, NCT04790344: Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.	Active, not recruiting	N/A	525	US	Investigational LUX-Dx ICM Implant	Boston Scientific Corporation	Heart Failure	05/26	06/26